Correlation Between Akero Therapeutics and Avidity Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Akero Therapeutics and Avidity Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akero Therapeutics and Avidity Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akero Therapeutics and Avidity Biosciences, you can compare the effects of market volatilities on Akero Therapeutics and Avidity Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akero Therapeutics with a short position of Avidity Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akero Therapeutics and Avidity Biosciences.

Diversification Opportunities for Akero Therapeutics and Avidity Biosciences

0.5
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Akero and Avidity is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Akero Therapeutics and Avidity Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avidity Biosciences and Akero Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akero Therapeutics are associated (or correlated) with Avidity Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avidity Biosciences has no effect on the direction of Akero Therapeutics i.e., Akero Therapeutics and Avidity Biosciences go up and down completely randomly.

Pair Corralation between Akero Therapeutics and Avidity Biosciences

Given the investment horizon of 90 days Akero Therapeutics is expected to generate 0.76 times more return on investment than Avidity Biosciences. However, Akero Therapeutics is 1.32 times less risky than Avidity Biosciences. It trades about 0.11 of its potential returns per unit of risk. Avidity Biosciences is currently generating about -0.02 per unit of risk. If you would invest  2,971  in Akero Therapeutics on August 29, 2024 and sell it today you would earn a total of  246.00  from holding Akero Therapeutics or generate 8.28% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Akero Therapeutics  vs.  Avidity Biosciences

 Performance 
       Timeline  
Akero Therapeutics 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Akero Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Akero Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.
Avidity Biosciences 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Avidity Biosciences are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat fragile basic indicators, Avidity Biosciences may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Akero Therapeutics and Avidity Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Akero Therapeutics and Avidity Biosciences

The main advantage of trading using opposite Akero Therapeutics and Avidity Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akero Therapeutics position performs unexpectedly, Avidity Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avidity Biosciences will offset losses from the drop in Avidity Biosciences' long position.
The idea behind Akero Therapeutics and Avidity Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Equity Valuation
Check real value of public entities based on technical and fundamental data
Bonds Directory
Find actively traded corporate debentures issued by US companies
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges